Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Ablation and Hematopoietic Stem Cell Support in Patients With Rheumatoid Arthritis and High Risk Factors

NCT00278551 is registered in ClinicalTrials.gov with Richard Burt, MD as lead sponsor.

NCT NCT00278551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00278551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Rheumatoid Arthritis and High Risk Factors
Lead sponsor
Richard Burt, MD
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 1997
Completion date
November 30, 2011
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis